LEUKEMIA INHIBITOR SUPPRESSES DIFFERENTIATION & IMMUNITY

白血病抑制剂抑制分化

• 批准号: 3173549
• 负责人: J. W. none CHIAO
• 金额: $ 19.66万
• 依托单位: NEW YORK MEDICAL COLLEGE
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-03-01 至 1990-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3173549
• 关键词: B lymphocyte; cell differentiation; cell growth regulation; cellular oncology; cytotoxicity; human tissue; leukocyte antigen typing; leukopoietic factor; myelogenous leukemia; neoplasm /cancer diagnosis; tissue /cell culture

We have successfully induced leukemic cells from myelogenous leukemia patienta and HL-60 promyelocyte-cell line to differentiate and mature to macrophages in a liquid culture assay. Conditioned culture medium (CM) of PHA-activated normal T cells contains the maturation-inducing activity. Analysis of total DNA content of single cells by flow cytometry demonstrated clearly that differentiated macrophages possess the same aneuploid DNA stemline as the undifferentiated patient cells, indicating leukemic cells can differentiate independently of genetic abnormality. The developmental process revealed that CM first induced most of the leukemic cells for one cell cycle division, then suppressed the DNA replication preceding mature cell expression. This process has also been delineated by reduction of RNA content, development of adherent cells, morphology, and acquisition of membrane receptors and functions. We hope these analyses of proliferation and maturation will represent a new and practical method to study leukemia. We are intending to study leukemic-patient cells with simultaneous application of the methods probing proliferation and differentiation defects. This includes the investigation of a lack of capacity to stop leukemic cells from replicating by comparing the suppressive activity of CM of patients with normal proliferation of HL-60 cells. Microassay technique to quantitate replicating cell number by autoradiography will be used. A possible excess or lack of proliferative stimulation will be studied by cross-testing CM of patients and of normal controls with patient and normal cells. Similar methods will be used with the culture assay to analyze whether there is a lack of CM maturation-inducing activity for their own cells, thereby blocking their differentiation. The development of isolated immature cells of normal bone marrow could be compared. We also intend to identify the subset of T cells producing the activities for cell proliferation, differentiation, and suppression of proliferation. Combining assays of proliferation and differentiation on the same cells will enable us to understand the controls of the leukemic cell growth. (MI)

我们已经成功地从骨髓性白血病中诱导出白血病细胞